Qianjiang Yongan Pharmaceutical Co (SZSE:002365) GF Value Rank : 3 (As of Jun. 05, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co GF Value Rank?

Qianjiang Yongan Pharmaceutical Co has the GF Value Rank of 3.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Qianjiang Yongan Pharmaceutical Co's GF Value Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Qianjiang Yongan Pharmaceutical Co's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qianjiang Yongan Pharmaceutical Co's GF Value Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qianjiang Yongan Pharmaceutical Co's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Qianjiang Yongan Pharmaceutical Co's GF Value Rank falls into.

Qianjiang Yongan Pharmaceutical Co GF Value Rank Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » GF Value Rank

Traded in Other Exchanges

N/A

Address

No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100

Website

http://www.chinataurine.com

Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.

Executives

Mei Song Lin	Executives
Wang Zhi Hua	Executives
Hong Ren Gui	Executives
Wu Yu Xi	Directors, executives
Dai Xiang Zhen	Executives
Wu Xiao Bo	Directors, executives
Luo Bai Neng	Executives
Ding Hong Li	Directors, executives
Fang Xi Quan	Executives
Li Shao Bo	Executives
Deng Yong Hong	Securities Affairs Representative
Dong Shi Hao	Executives
Wu Guo Sen	Supervisors
Lv Xin Wu	Executives
Chen Yong	Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines